Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

'Science to Market': a New Forum for Pharmaceutical Biotechnology.


HANNOVER, Germany -- 16th International Trade Fair, Conferences, Partnering and Award for Biotechnology

BIOTECHNICA 2008 has a new forum for pharmaceutical biotechnology. For the first time, the European Association of Pharma Biotechnology (EAPB) - in cooperation with the science congress European BioPerspectives - will be hosting the conference "Science to Market". The aim of this European event is to promote partnerships between science and industry in the field of pharmaceutical biotechnology in order to drive forward the ongoing development of marketable technologies and biopharmaceutical products.

The two-day conference will focus on developments relating to relating to relate prepconcernant

relating to relate prepbezüglich +gen, mit Bezug auf +acc 
 new biopharmaceutical drugs and diagnostic methods and on innovative technologies used in the development and manufacture of biopharmaceutical products. Subjects under discussion will include second-generation biopharmaceuticals, new vaccines, advances in gene therapy, drug formats and methods for improving the manufacture and analysis of today's biopharmaceuticals.

The program will be rounded off by distinguished keynote speakers: Andreas Pluckthun, University of Zurich History
The University of Zurich was founded in 1833 with existing colleges of theology (founded by Huldrych Zwingli in 1525), law and medicine merged together with a new faculty of Philosophy.
, will report on "Rational protein design - In vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment.

in vi·tro
adj.
In an artificial environment outside a living organism.
 evolution of antibody therapeutics", Stephen Minger minger
Noun

Brit informal unattractive person
, King's College King's College, former name of Columbia Univ.  London, will discuss the "Therapeutic and research potential of human stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young ", and Christopher Baum, Hannover Medical School The Hannover Medical School (abbreviated MHH in German), founded in 1965, is one of the world's leading university medical centres in Germany. The research and patient care set national and international standards. , will speak about "Gene therapy - from basic science to clinical application".

Further information about the event can be found on the Internet at www.eapb.org.

What is BIOTECHNICA?

BIOTECHNICA in Hannover is the leading event within the European biotech industry. It embraces every segment of biotechnology - from basic biotechnology and equipment, bio-informatics and services to the five major areas of application: pharmaceuticals/medicine, industry, food, agriculture, the chemical industry and the environment. BIOTECHNICA has been organized by Deutsche Messe AG at the Hannover Exhibition Grounds since 1985. Today, BIOTECHNICA events - BIOTECH CHINA in Asia and BIOTECHNICA AMERICA in the USA - are also held across the globe.

Further press releases and photos can be found at: www.biotechnica.de/pressservice
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 12, 2008
Words:305
Previous Article:Research and Markets: Global Electrical Equipment Provides Textual Analysis of the Industry's Recent Performance and Future Prospects.
Next Article:Research and Markets: Global Semiconductors & Semiconductor Equipment.
Topics:



Related Articles
Data From 510(k) Statements.
Grabbing the life sciences ring: it's tough to do with 50 hands out.
Prescription for research; Academia, industry cooperate.
Pondering biotech; Sector is robust, with ambitious plans to grow.
Belgian Pharmaceutical Company Qualiphar-Gifrer Signs Deal to Establish Base at DuBiotech.
Advanstar Communications acquires CBI Research.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles